Amarin Corporation plc (NASDAQ:AMRN) price on Thursday, August 26, fall -1.27% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $5.77.
A look at the stock’s price movement, the level at last check in today’s session was $5.84, moving within a range at $5.68 and $5.85. The beta value (5-Year monthly) was 2.25 while the PE ratio in trailing twelve months stood at 530.91. Turning to its 52-week performance, $9.25 and $3.36 were the 52-week high and 52-week low respectively. Overall, AMRN moved 46.00% over the past month.
Amarin Corporation plc’s market cap currently stands at around $2.31 billion, with investors looking forward to this quarter’s earnings report slated for Nov 03, 2021 – Nov 08, 2021. Analysts project the company’s earnings per share (EPS) to be -$0.03, which has seen fiscal year 2021 EPS growth forecast to increase to -$0.06 and about -$0.1 for fiscal year 2022. Per the data, EPS growth is expected to be -20.00% for 2021 and -66.70% for the next financial year.
Analysts have a consensus estimate of $152.69 million for the company’s revenue for the quarter, with a low and high estimate of $138.15 million and $162.59 million respectively. Wall Street analysts have also projected the company’s year-on-year revenue for 2021 to grow to $636.52 million, representing a 3.70% jump on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that AMRN is a 50% Buy. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
7 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 4 recommend AMRN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
The technical evaluation for the stock shows the PEG ratio is 13.65, with AMRN’s current price about 13.57% and 23.50% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 67.60, while 7-day volatility ratio is 5.42% and 5.85% in the 30-day chart. Further, Amarin Corporation plc (AMRN) has a beta value of 2.18, and an average true range (ATR) of 0.28. Analysts have given the company’s stock an average 52-week price target of $10.13, forecast between a low of $5.00 and high of $19.00. Looking at the price targets, the low is 13.34% off recent price level in today’s trading while to achieve the yearly target high, it has to move -229.29%. Nonetheless, investors will most likely welcome a -73.31% jump to $10.00 which is the analysts’ median price.
In the market, a comparison of Amarin Corporation plc (AMRN) and its peers suggest the former has performed considerably weaker. Data shows AMRN’s intraday price has changed -1.27% today and -12.57% over the past year. Comparatively, AstraZeneca PLC (AZN) has moved 0.50% so far today and only 2.75% in the past 12 months. Looking at another peer, we see that Ionis Pharmaceuticals Inc. (IONS) price has dipped -0.40% on the day. However, the stock is -25.26% off its price today a year ago. Moreover, AbbVie Inc. (ABBV) is also up 0.09% in today’s trading while keeping a an uptrend of 28.00% over the past year. If we look at the PE ratio, we find that Amarin Corporation plc’s ratio stands at 530.91 compared to AstraZeneca PLC’s 40.88. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -0.35% and -0.14% respectively on the day as seen in early trades.
If we refocus on Amarin Corporation plc (NASDAQ:AMRN), historical trading data shows that trading volumes averaged 4.59 million over the past 10 days and 3.78 million over the past 3 months. The company’s latest data on shares outstanding shows there are 395.90 million shares.
The 1.20% of Amarin Corporation plc’s shares are in the hands of company insiders while institutional holders own 33.70% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 25.08 million on Jun 14, 2021, giving us a short ratio of 9.76. The data shows that as of Jun 14, 2021 short interest in Amarin Corporation plc (AMRN) stood at 6.35% of shares outstanding, with shares short rising to 24.49 million registered in May 13, 2021. Current price change has pushed the stock 19.43% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AMRN stock continues to rise going into the next quarter.